EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

LINC00941 Drives Chemoresistance via Modulating PKM2 Activity and Aerobic Glycolysis in Oral Squamous Cell Carcinoma

Shule Xie, Lianxi Mai, Yu Peng, Wenhao Sun, Yupeng Wu, Yingnan Ma, Renquan Liu, Liang Qiao, Yangu Tao, Guoxin Huang, Zhaoyu Lin

Cancer Letters · 2026-08 · 218775

DOI: 10.1016/j.canlet.2026.218775 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2026-08. Verfasst von Shule Xie und 10 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangz…. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shantou Science and Technology Project, Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cisplatin (CDDP) resistance represents a major determinant of poor prognosis in patients with oral squamous cell carcinoma (OSCC). While long non-coding RNAs (lncRNAs) are implicated in chemoresistance pathways, their mechanistic roles in OSCC treatment failure remain incompletely defined. This study identifies LINC00941 as a CDDP resistance-associated lncRNA, with elevated expression correlating significantly with adverse OSCC prognosis. Gain- and loss-of-function assays reveal that LINC00941 overexpression promotes both aerobic glycolysis and CDDP resistance in OSCC cells. Furthermore, elevated LINC00941 expression enhances pyruvate kinase activity, thereby fostering chemoresistance in vitro and in vivo. Mechanistic investigations reveal that LINC00941 physically interacts with pyruvate kinase M2 (PKM2), enhancing its protein stability by suppressing ubiquitin-mediated proteolysis. This stabilization amplifies glycolytic flux, ultimately inducing CDDP resistance in OSCC cells. Our findings elucidate a novel lncRNA-dependent pathway governing chemoresistance and propose targeting the LINC00941/PKM2/glycolysis axis as a translatable therapeutic strategy for overcoming CDDP resistance in OSCC.

Schlagwörter

Stichwörter der Autor:innen

Aerobic glycolysisChemoresistanceLncRNAOral Squamous Cell Carcinoma

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou,510120, China; Department of Oral & Maxillofacial Surgery, Sun Yat…
  • Department of Stomatology, The First Affiliated Hospital, Medical College of Shantou University, Shantou, 515064, China.
  • Storr Liver Centre, Westmead Institute for Medical Research, University of Sydney at Westmead Hospital, Westmead, NSW, 2145, Australia. Electronic address: liang.qiao@sydney.edu.au.
  • Department of Traditional Chinese Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China. Electronic address: taoyg@mail.sysu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Shantou Science and Technology Project
  • Natural Science Foundation of Guangdong Province

Zitieren

APA

Xie, S., Mai, L., Peng, Y., Sun, W., Wu, Y., Ma, Y., Liu, R., Qiao, L., Tao, Y., Huang, G., & Lin, Z. (2026). LINC00941 Drives Chemoresistance via Modulating PKM2 Activity and Aerobic Glycolysis in Oral Squamous Cell Carcinoma. Cancer Letters, 218775. https://doi.org/10.1016/j.canlet.2026.218775

Vancouver

Xie S, Mai L, Peng Y, Sun W, Wu Y, Ma Y, et al. LINC00941 Drives Chemoresistance via Modulating PKM2 Activity and Aerobic Glycolysis in Oral Squamous Cell Carcinoma. Cancer Letters. 2026:218775. doi:10.1016/j.canlet.2026.218775

BibTeX
@article{Xie2026,
  author = {Xie, Shule and Mai, Lianxi and Peng, Yu and Sun, Wenhao and Wu, Yupeng and Ma, Yingnan and Liu, Renquan and Qiao, Liang and Tao, Yangu and Huang, Guoxin and Lin, Zhaoyu},
  title = {LINC00941 Drives Chemoresistance via Modulating PKM2 Activity and Aerobic Glycolysis in Oral Squamous Cell Carcinoma},
  journal = {Cancer Letters},
  year = {2026},
  pages = {218775},
  doi = {10.1016/j.canlet.2026.218775}
}
Kostenlos starten →